ROIV
ROIVANT SCIENCES LTD
ROIVANT SCIENCES LTD historical holders
total: 3
Polen Capital Management ROIVANT SCIENCES LTD transactions over time
- Total transactions:
- 3
- New positions:
- 2
- Sold out:
- 1
- Held since:
- 2026 Q2
- Held for:
- 1 quarter
- Latest activity:
- 2026 Q2
Polen Capital Management has been an institutional investor in ROIVANT SCIENCES LTD (ROIV) since 2025 Q4. According to 2026 Q2 report, Polen Capital Management holds 8,659 shares with a market value of roughly $306.44K representing 0.00% of their equity portfolio. The fund/company first acquired ROIV in 2025 Q4, initially purchasing 9,662 shares. Polen Capital Management later completely sold out the position and reinvested in ROIV again in 2026 Q2. Since the initial investment, Polen Capital Management has made 2 more transactions in this position.
Does Polen Capital Management still hold ROIV?
Yes, Polen Capital Management continues to hold ROIVANT SCIENCES LTD (ROIV). According to their 2026 Q2 report, they maintain a position of 8,659 shares valued at approximately $306.44K, representing 0.00% of their equity portfolio.
When did Polen Capital Management first invest in ROIV?
Polen Capital Management first invested in ROIVANT SCIENCES LTD (ROIV) in 2025 Q4 at the reported quarter-end price of $21.70 per share, acquiring 9,662 shares in their initial purchase.
What is Polen Capital Management's average cost basis for ROIV?
Based on historical transaction data, Polen Capital Management's estimated cost basis for ROIVANT SCIENCES LTD (ROIV) is approximately $35.39 per share. This represents their average reported price* across all buy transactions.
Has Polen Capital Management reinvested in ROIV after selling?
Yes, Polen Capital Management has shown renewed interest in ROIVANT SCIENCES LTD (ROIV). After completely selling their position, they reinitiated an investment in 2026 Q2, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $35.39
ROIV transactions history by Polen Capital Management
3 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
0.00%
|
8,659
|
$35.39
|
$306,442
|
new
|
+0%
|
|
2026 Q1
|
0.00%
|
0
|
$21.70
|
|
-100% (-9,662)
|
-0%
|
|
2025 Q4
|
0.00%
|
9,662
|
$21.70
|
$209,665
|
new
|
+0%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.